We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mass Spec Predicts Improved Response to Anti-HER2 Therapy in Breast Cancer

News   Jul 07, 2014

 
Mass Spec Predicts Improved Response to Anti-HER2 Therapy in Breast Cancer
 
 
 

RELATED ARTICLES

Leukemia Stem Cells Rely on Amino Acids for Survival

News

Clinically relevant eradication of leukemia stem cells could be achieved with drugs that target their metabolic vulnerabilities.

READ MORE

Ketone Shuttle Coordinates Response to Liver Fibrosis

News

A metabolite shuttle, or dialogue, provides a connection between hepatocyte and macrophage cell types in the liver and helps protect against tissue fibrosis.

READ MORE

Anti-Malaria Drugs Show Promise in Treating Cancer – Now We Know Why

News

Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers say they have identified that target - an enzyme called PPT1 - opening up a new pathway for potential cancer treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE